Business Segments

9 Months Ended

Oct. 01, 2022

Segment Reporting [Abstract]

Business Segments

11. Business Segments

The Company operates in one segment, ophthalmology. The Company develops, manufactures and markets medical devices. Our revenues arise from the sale of consoles, delivery devices, consumables, service, and support activities.

Revenue information shown by product group is as follows:

	Three Months Ended				Nine Months Ended
(in thousands)	October 1, 2022		October 2, 2021		October 1, 2022		October 2, 2021
Cyclo G6	$	3,460	$	3,145	$	10,477	$	10,093
Retina		8,750		7,777		23,580		22,012
Other(1)		2,425		2,342		7,720		6,544
Total revenues	$	14,635	$	13,264	$	41,777	$	38,649

(1) Includes service contract revenues of $358 thousand and $387 thousand and $1,122 thousand and $1,061 thousand recognized during the three and nine months ended October 1, 2022 and October 2, 2021, respectively. Includes $351 thousand and $228 thousand and $985 thousand and $339 thousand recognized revenue related to the exclusive distribution rights during the three and nine months ended October 1, 2022 and October 2, 2021, respectively. Other also includes revenues from paid service, royalty, freight and legacy G probes.

Revenue information shown by geographic region, based on the sales destination, is as follows:

	Three Months Ended				Nine Months Ended
(in thousands)	October 1, 2022		October 2, 2021		October 1, 2022		October 2, 2021
United States	$	7,415	$	6,674	$	20,806	$	18,634
Europe, Middle East and Africa		3,480		3,215		9,732		8,925
Asia/Pacific Rim		2,910		2,862		8,949		9,378
Rest of Americas		830		513		2,290		1,712
Total revenues	$	14,635	$	13,264	$	41,777	$	38,649

Revenues are attributed to countries based on the location of end customers.

Other than the United States, the Netherlands accounted for at least 10% of the Company’s revenues during the three and nine months ended October 1, 2022, representing 14% and 10%, respectively. Other than the United States, the Netherlands accounted for at least 10% of the Company's revenues during the three months ended October 2, 2021, representing 10%. Other than the United States, Japan accounted for more than 10% of the Company’s revenues during the nine months ended October 2, 2021, representing 13%. The United States accounted for 50.7% and 50.3% of revenues for the three months ended October 1, 2022 and October 2, 2021, respectively, and for 49.8% and 48.2% of revenues for the nine months ended October 1, 2022 and October 2, 2021, respectively.